Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 87

Sort by

Sort Order Select

Journal Articles

A Gain of Function Mutation in the NSD2 Histone Methyltransferase Drives Glucocorticoid Resistance Via Blocking Receptor Auto-Induction and BIM/Bmf Expression in ALL

Blood (2019) 134 (Supplement_1): 3758.

https://doi.org/10.1182/blood-2019-126910

Published: 2019

Journal Articles

Impact of Targeted Immunotherapies and Novel Cytogenetic and Clinical Risk Groups on Outcome after Allogeneic Hematopoietic Stem Cell Transplant (AlloHCT) for Acute Lymphoblastic Leukemia (ALL): The Mayo Clinic Cohort

Zaid Abdel Rahman, MD, Michael G. Heckman, Kevin C. Miller, BS, Patricia Greipp, DO, Matthew R Spiegel, Sharad Khurana, MDMSc, Hassan B. Alkhateeb, MD, Mrinal M Patnaik, MDMBBS, Lisa Z. Sproat, MD, Liuyan Jiang, Vivek Roy, MD, Mark Litzow, MD, Mohamed A Kharfan-Dabaja, MDMBA, William J Hogan, MB, BCh, James M. Foran, MD

Blood (2019) 134 (Supplement_1): 2588.

https://doi.org/10.1182/blood-2019-122068

Published: 2019

Journal Articles

Oral Adherence in Adults with Acute Myeloid Leukemia: Results of a Mixed Methods Study

Ashley Leak Bryant, PhD RN, Thomas W. LeBlanc, MDMA,MHS, Tara Albrecht, PhDANP, Ya-Ning Chan, Jaime Richardson, Matthew C Foster, MD, Dang Malisa, Susie Owenby, Debra Wujcik, PhD

Blood (2019) 134 (Supplement_1): 2215.

https://doi.org/10.1182/blood-2019-130514

Published: 2019

Journal Articles

POD24 in MZL: a means to an end or an end point in itself?

Matthew J. Maurer

Blood (2019) 134 (10): 787–788.

https://doi.org/10.1182/blood.2019002305

Published: 2019

Journal Articles

The Demographic, Clinical and Survival Rate of Classical Hogkings Lymphoma Patients in Oman, Retrospective Study

Khalid Nasser Al Hashmi, Kamla Alwahaibi, Murtadha K. Al-Khabori, BSc, MD FRCPC, MSc

Blood (2018) 132 (Supplement 1): 5369.

https://doi.org/10.1182/blood-2018-99-114957

Published: 2018

Journal Articles

Conditional Survival and Mortality Risks after Allogeneic Hematopoietic Cell Transplantation (alloHCT) in Patients Who Survived Varying Length of Time after Allohct

F. Lennie Wong, PhD, Meisi Xiao, MPH, Jennifer Berano Teh, Liezl Atencio, Alicia Gonzales, Amy Hinton, David Iukuridze, Stephen J Forman, Ryotaro Nakamura, MD, Saro H. Armenian, DO,MPH

Blood (2018) 132 (Supplement 1): 368.

https://doi.org/10.1182/blood-2018-99-112646

Published: 2018

Journal Articles

Is There Difference between the Survival Rate and Treatment Related Complications between Peripheral Blood Stem Cell Transplantation and Bone Marrow Transplantation for Pediatric Hematological Malignancy?: Systematic Review and Meta-Analysis

Yuko Shimosato-Wada, Reo Tanoshima, Shinichi Tujimoto, Masanobu Takeuchi, Norio Shiba, MD PhD, Tohru Kobayashi, MD PhD, Shuichi Ito, MD PhD

Blood (2018) 132 (Supplement 1): 3378.

https://doi.org/10.1182/blood-2018-99-112306

Published: 2018

Journal Articles

Survival of AML Patients Relapsing after Hematopoetic Stem Cell Transplantation: A Single Center Experience

Pelin Aytan, MD, Mahmut Yeral, MD, Aslı Korur, MD, Cigdem Gereklioglu, MD, Funda Tanrıkulu, MD, Mutlu Kasar, MD, Soner Solmaz, MD, Nurhilal Buyukkurt, MD, Suheyl Asma, MD, Ilknur Kozanoglu, MD, Hakan Ozdogu, MD, Can Boga, MD

Blood (2018) 132 (Supplement 1): 5581.

https://doi.org/10.1182/blood-2018-99-118046

Published: 2018

Journal Articles

Relapse and Mortality Prediction of Acute Myeloid Leukemia Patients Using Deep Bidirectional Long Short-Term Memory-Deep Neural Network Architecture

Bor-Sheng Ko, MD PhD, Yu-Fen Wang, MS, Chih-Chuan Lu, B.S., Jeng-Lin Li, BS, Chi-Chun Lee, PhD, Jih-Luh Tang, MD, Hwei-Fang Tien, MD, PhD

Blood (2018) 132 (Supplement 1): 2811.

https://doi.org/10.1182/blood-2018-99-115778

Published: 2018

Journal Articles

Genetic Characterization of ABT-199 Sensitivity in Human AML

Marie-Eve Bordeleau, PhD, Richard Bisaillon, PhD, Clarisse Thiollier, PhD, Jana Krosl, PhD, Bernhard Lehnertz, PhD, Vincent-Philippe Lavallee, MD, Tara MacRae, Labelle Caroline, Geneviève Boucher, Isabel Boivin, Giovanni D'Angelo, Sylvie Lavallée, Anne Marinier, PhD, Sébastien Lemieux, PhD, Josée Hébert, MD, Guy Sauvageau, MD, PhD

Blood (2018) 132 (Supplement 1): 283.

https://doi.org/10.1182/blood-2018-99-113062

Published: 2018

Journal Articles

Is There an Increase in Sickle Cell Related Events Among the Adult Belgian Population?

Phu-Quoc Le, MD PhD, Beatrice Gulbis, MD PhD, Laurence Dedeken, MD, Laurence Rozen, Christiane Vermylen, MD PhD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, Christine Devalck, MD, Fleur Samantha Benghiat, Andre Efira, MD, Marie-Françoise Dresse, MD PhD, Alina Ferster, MD

Blood (2018) 132 (Supplement 1): 4923.

https://doi.org/10.1182/blood-2018-99-119319

Published: 2018

Journal Articles

Long-Term Survival after Autologous Stem Cell Transplantation in a Colombian Population

Claudia Lucia Sossa, Luis Antonio Salazar, MD, Angela María Peña, MD, Edgar Gomez, MD, Claudia Marcela Chalela, MD, David Leonardo Reyes, MD, Manuel Rosales, MD, Jose Sandoval-Sus, MD, Sonia Osma, MD, Maria Luna-Gonzalez, Sergio Serrano, MD, Sara Ines Jimenez, MD

Blood (2018) 132 (Supplement 1): 4626.

https://doi.org/10.1182/blood-2018-99-119715

Published: 2018

Journal Articles

Real-World Differences in Characteristics and Survival of Relapsed AML Patients with and without Transplant

Abdalla Aly, Saurabh Ray, Anuj Shah, PhD, Marc Botteman, MS, MA

Blood (2018) 132 (Supplement 1): 2297.

https://doi.org/10.1182/blood-2018-99-118621

Published: 2018

Journal Articles

Autologous Transplantation Improves Survival Rates for Follicular Lymphoma Patients Who Relapse within 2-Years of Chemoimmunotherapy: A Multi-Centre Retrospective Analysis of Consecutively Treated Patients in the Real World

Mita Manna, MD FRCPC, Richard Lee-Ying, MD FRCPC, Gwynivere Davies, MDFRCPC, Anthea Peters, MSc, MD FRCPC, Danielle Oh, MD, Colin Stewart, Douglas A. Stewart

Blood (2017) 130 (Supplement 1): 3298.

https://doi.org/10.1182/blood.V130.Suppl_1.3298.3298

Published: 2017

Journal Articles

ONC213, a Novel Second Generation Analog of ONC201, Shows Promising Anti-Leukemic Activity Against AML Cells In Vitro and In Vivo

Yongwei Su, Xinyu Li, Holly Edwards, Joshua E. Allen, PhD, Martin Stogniew, Varun Vijay Prabhu, BPharm, MS, PhD, Jeffrey W. Taub, MD, Hai Lin, Yubin Ge, PhD

Blood (2017) 130 (Supplement 1): 3822.

https://doi.org/10.1182/blood.V130.Suppl_1.3822.3822

Published: 2017

Journal Articles

Real World Data: Delay on Symptoms and Diagnosis Recognition Associated with Relapse and Death in Thrombocytopenic Thrombotic Purpura (PTT)

Marcus Vinicius Ludwig, Laura Fogliatto, MD, Kamila Grokoski, Lucia Silla, MD PhD, Paz Aparecida Alessandra, Liane Esteves Daudt, MD, Carolina Fusinato Molin, Giane Durigon, Arturo Freja, Alini Vargas, Leo Sekine

Blood (2017) 130 (Supplement 1): 4858.

https://doi.org/10.1182/blood.V130.Suppl_1.4858.4858

Published: 2017

Journal Articles

Precision Targeting of Ion Channel Blocker for the Treatment of AML

David Marshall, BS, Antonella Chillemi, PhD, Fabio Malavasi, MD, James Prudent, PhD

Blood (2017) 130 (Supplement 1): 5203.

https://doi.org/10.1182/blood.V130.Suppl_1.5203.5203

Published: 2017

Journal Articles

Clonal Evolution Mechanisms and Collateral Sensitivity to Impdh Inhibitor Therapy in Relapsed Lymphoblastic Leukemia

Chelsea Dieck, Gannie Tzoneva, PhD, Koichi Oshima, MD PhD, Alberto Ambesi-Impiombato, Marta Sanchez-Martin, PhD, Maria Luisa Sulis, MD, Motohiro Kato, MD PhD, Katsuyoshi Koh, MD, Maddalena Paganin, PhD, Giuseppe Basso, MD, Julie M. Gastier-Foster, PhD, Mignon L. Loh, MD, Renate Kirschner-Schwabe, PhD, Chioma Madubata, Raul Rabadan, Adolfo A. Ferrando, MD PhD

Blood (2017) 130 (Supplement 1): 2602.

https://doi.org/10.1182/blood.V130.Suppl_1.2602.2602

Published: 2017

Journal Articles

Survival Rates and Clinical Characteristics of Young Patients with Waldenström Macroglobulinemia

Amaara Babwah, MS, Joshua Gustine, Kirsten Meid, MPH, Toni Dubeau, NP, Patricia Severns, NP, Steven P Treon, MDPhDFRCP, Jorge J. Castillo, MD

Blood (2017) 130 (Supplement 1): 4043.

https://doi.org/10.1182/blood.V130.Suppl_1.4043.4043

Published: 2017

Journal Articles

Economic Evaluation of Carfilzomib+Dexamethasone (Kd) Vs Bortezomib+Dexamethasone (Vd) in Relapsed or Refractory Multiple Myeloma (R/RMM)

Andrzej Jakubowiak, MD PhD, Istvan Matyas Majer, PhD, Ivan Houisse, MSc, Agnes Benedict, Marco Campioni, Sumeet Panjabi, Sikander Ailawadhi, MD

Blood (2016) 128 (22): 3582.

https://doi.org/10.1182/blood.V128.22.3582.3582

Published: 2016

NARROW

A Gain of Function Mutation in the NSD2 Histone Methyltransferase Drives Glucocorticoid Resistance Via Blocking Receptor Auto-Induction and BIM/Bmf Expression in ALL

Impact of Targeted Immunotherapies and Novel Cytogenetic and Clinical Risk Groups on Outcome after Allogeneic Hematopoietic Stem Cell Transplant (AlloHCT) for Acute Lymphoblastic Leukemia (ALL): The Mayo Clinic Cohort

Oral Adherence in Adults with Acute Myeloid Leukemia: Results of a Mixed Methods Study

POD24 in MZL: a means to an end or an end point in itself?

The Demographic, Clinical and Survival Rate of Classical Hogkings Lymphoma Patients in Oman, Retrospective Study

Conditional Survival and Mortality Risks after Allogeneic Hematopoietic Cell Transplantation (alloHCT) in Patients Who Survived Varying Length of Time after Allohct

Is There Difference between the Survival Rate and Treatment Related Complications between Peripheral Blood Stem Cell Transplantation and Bone Marrow Transplantation for Pediatric Hematological Malignancy?: Systematic Review and Meta-Analysis

Survival of AML Patients Relapsing after Hematopoetic Stem Cell Transplantation: A Single Center Experience

Relapse and Mortality Prediction of Acute Myeloid Leukemia Patients Using Deep Bidirectional Long Short-Term Memory-Deep Neural Network Architecture

Genetic Characterization of ABT-199 Sensitivity in Human AML

Is There an Increase in Sickle Cell Related Events Among the Adult Belgian Population?

Long-Term Survival after Autologous Stem Cell Transplantation in a Colombian Population

Real-World Differences in Characteristics and Survival of Relapsed AML Patients with and without Transplant

Autologous Transplantation Improves Survival Rates for Follicular Lymphoma Patients Who Relapse within 2-Years of Chemoimmunotherapy: A Multi-Centre Retrospective Analysis of Consecutively Treated Patients in the Real World

ONC213, a Novel Second Generation Analog of ONC201, Shows Promising Anti-Leukemic Activity Against AML Cells In Vitro and In Vivo

Real World Data: Delay on Symptoms and Diagnosis Recognition Associated with Relapse and Death in Thrombocytopenic Thrombotic Purpura (PTT)

Precision Targeting of Ion Channel Blocker for the Treatment of AML

Clonal Evolution Mechanisms and Collateral Sensitivity to Impdh Inhibitor Therapy in Relapsed Lymphoblastic Leukemia

Survival Rates and Clinical Characteristics of Young Patients with Waldenström Macroglobulinemia

Economic Evaluation of Carfilzomib+Dexamethasone (Kd) Vs Bortezomib+Dexamethasone (Vd) in Relapsed or Refractory Multiple Myeloma (R/RMM)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only